Both in Pharmaceuticals
Soligenix vs Moleculin Biotech
Over the past year SNGX returned −76.4% and MBRX returned −96.5%; their daily moves had a correlation of -0.01.
SNGX −76.4% MBRX −96.5%Growth of $1, one year, split-adjusted
| Metric | SNGX | MBRX |
|---|---|---|
| Price | $0.3559 | $7.90 |
| Market cap | $7.7M | $8.1M |
| Today | −3.63% | −9.40% |
| 1 month | −2.2% | −21.6% |
| 6 months | +3.2% | −84.3% |
| Year to date | −73.4% | −88.1% |
| 1 year | −77.3% | −96.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 42.0% | 850.8% |
| Short % of float | 0.8% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).